Background: Two main forms of amiodarone-induced thyrotoxicosis (AIT) exist: type 1 AIT is
a condition of true hyperthyroidism developing in patients with pre-existing thyroid disorders …

Objective Considering the different pathogenic mechanisms of the two main forms of
amiodarone-induced thyrotoxicosis (AIT), we ascertained whether this results in a different …

Background: Amiodarone-induced thyrotoxicosis (AIT) type 1 occurs in subjects with an
underlying thyroid disease, whereas type 2 AIT is a form of destructive thyroiditis. Our …

Context: Amiodarone-induced thyrotoxicosis (AIT) resulting from destructive thyroiditis (type
2) is commonly treated with glucocorticoids, but time needed to restore euthyroidism may be …

Context: Type 2 amiodarone-induced thyrotoxicosis (AIT) is a destructive thyroiditis usually
responsive to glucocorticoids. Whether continuation of amiodarone affects treatment …

Purpose Type 2 amiodarone-induced thyrotoxicosis (AIT2) is a form of drug-induced
destructive thyroiditis, usually treated with oral glucocorticoids (oGCs). Our objective was to …

Amiodarone-induced thyroid dysfunction occurs in 15–20% of amiodarone-treated patients.
Amiodarone-induced hypothyroidism (AIH) does not pose relevant problems, is easily …

Context: Type 2 amiodarone-induced thyrotoxicosis (AIT) is a destructive thyroiditis usually
responsive to glucocorticoids; however, recent surveys showed that many expert …

Introduction Amiodarone is a widely used anti-arrhythmic drug. A common long-term
complication is amiodarone-induced thyrotoxicosis (AIT). We examined retrospectively the …

The incidence of type 2 amiodarone-induced thyrotoxicosis (AIT) is increasing. A new study
provides evidence that glucocorticoid therapy is safe, effective and associated with prompt …